At least 5,800 people have fallen ill or tested positive for covid two weeks or more after being fully vaccinated, according to the CDC. “I now tell everyone, including my colleagues, not to let their guard down.”
The law provides money to enhance coronavirus testing and contact tracing, support federal efforts on vaccine distribution and hire more public health workers. But advocates worry support will wane when the pandemic is over.
Reaching people who may have been in contact with covid patients has helped cut the number of infections, but these tracing efforts become less effective as the number of cases grows.
Enacted in March, an emergency measure covers about half of full-time workers nationwide, permitting 10 days of paid sick leave for all who fall ill or need to quarantine, and 50 more days of extended leave for parents who need to care for a child at home due to COVID-related school or day care closures.
Millions of people have lost their jobs and health insurance since March, and experts say many of those looking for a plan on the ACA marketplace may not be able to get the assistance they need.
Relentlessly knocked around by politics and now headed again to the Supreme Court, the ACA is covering millions who have lost their jobs during the pandemic. But not everyone.
Many physicians were forced to close their offices — or at least see only emergency cases — when the pandemic struck. Because they are generally paid piecemeal for every service, they suffered big losses, leading to layoffs and pay cuts. Some doctors say they now are looking to overhaul the way they get paid.
With most nonemergency procedures shelved for now, many health insurers are expected to see profits in the near term, but the longer view of how the coronavirus will affect them is far more complicated and could well impact what people pay for coverage next year.
The new law reclassifies many independent contractors as employees, requiring they be offered a range of benefits. But that could have unintended consequences, experts warn.
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.